NCT02622386View on ClinicalTrials.gov

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 11, 2016

Primary Completion Date

April 6, 2020

Study Completion Date

April 6, 2020

Conditions
Psoriasis
Interventions
DRUG

Riboflavin

Riboflavin (Vitamin B2) 400 mg capsule taken daily for 12 weeks.

OTHER

Placebo

Matching placebo capsule taken daily for 12 weeks.

Trial Locations (1)

48109

University of Michigan Department of Dermatology, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02622386 - The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis | Biotech Hunter | Biotech Hunter